Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HealthEquity, Inc. - Common Stock (NQ: HQY )

95.39 +1.42 (+1.51%)
Streaming Delayed Price Updated: 10:11 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about HealthEquity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Here's How Much $100 Invested In HealthEquity 10 Years Ago Would Be Worth Today
Via Benzinga
HEALTHEQUITY INC (NASDAQ:HQY): a strong growth stock preparing for the next leg up?.
Based on fundamental and technical analysis of NASDAQ:HQY we conclude: HEALTHEQUITY INC (NASDAQ:HQY): a strong growth stock preparing for the next leg up?. 
Via Chartmill
What Analysts Are Saying About HealthEquity Stock
Via Benzinga
Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years
Via Benzinga
Here's How Much $100 Invested In HealthEquity 10 Years Ago Would Be Worth Today
Via Benzinga
NASDAQ:HQY: a strong growth stock preparing for the next leg up?.
Based on a technical and fundamental analysis of NASDAQ:HQY we conclude: HEALTHEQUITY INC (NASDAQ:HQY)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
NASDAQ:HQY—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
HEALTHEQUITY INC (NASDAQ:HQY): a strong growth stock preparing for the next leg up?. 
Via Chartmill
Insights into HealthEquity Q3 Earnings
Via Benzinga
Earnings Breakdown: HealthEquity Q3
Via Benzinga
Paychex Stock Gets Technical Rating Upgrade
Paychex stock had its Relative Strength Rating upgraded to 75 Wednesday — a nice improvement, but shy of the 80-plus score you prefer to see. 
Via Investor's Business Daily
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Yext, Oracle, Huize Holding And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
HealthEquity Earnings Analysis: Q3 Recap
Via Benzinga
Earnings Summary: HealthEquity Q3
Via Benzinga
HealthEquity Q3 Earnings Assessment
Via Benzinga
HealthEquity Earnings Report: Q3 Overview
Via Benzinga
NASDAQ:HQY—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
HEALTHEQUITY INC (NASDAQ:HQY), a strong growth stock, setting up for a breakout. 
Via Chartmill
Earnings Scheduled For December 9, 2024
Via Benzinga
Insights into HealthEquity's Upcoming Earnings
Via Benzinga
Expert Ratings For HealthEquity
Via Benzinga
Netflix To Rally More Than 7%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why NASDAQ:HQY Is a Standout High-Growth Stock in a Consolidation Phase.
Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
In-Depth Examination Of 8 Analyst Recommendations For HealthEquity
Via Benzinga
Why NASDAQ:HQY Is a Promising High-Growth Stock in the Midst of Consolidation.
Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
As the presidential election results come in, market reactions leave investors wondering where the next best step may come from. 
Via MarketBeat
Topics Bonds ETFs Economy
Exposures Debt Markets Economy Political
How Will HealthEquity, Other Medtechs Do Under Harris Or Trump Administration?
It has a near-perfect 96 Composite Rating and a C+ Accumulation/Distribution Rating, showing that big funds are buying its shares. 
Via Investor's Business Daily
Topics Government
Exposures Political
Buckle Up And Use Volitility To Your Advantage
The Advance/Decline trend on the NYSE weakened; the Nasdaq A/D line is outright scary. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.